Literature DB >> 35697863

Clinical relevance of glomerular C4d deposition in children with early IgA nephropathy or Henoch-Schönlein purpura nephropathy.

Dan Wu1, Lei Lei1, Hejia Zhang1, Xingfeng Yao2, Zhi Chen1, Nan Zhang2, Jie Ni1, Chen Ling1, Xiaorong Liu3, Xiangmei Chen4.   

Abstract

BACKGROUND: Both IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephropathy (HSPN) are characterized by glomerular mesangial IgA deposition. Several large studies on adults have suggested that glomerular C4d deposition has prognostic value in IgAN. However, there are few relevant studies on the clinical value of C4d deposition in children with IgAN or HSPN.
METHODS: We performed a retrospective cohort study in pediatric patients with IgAN or HSPN. Clinicopathological data were collected at the time of kidney biopsy. Kidney C4d deposition was analyzed by immunohistochemistry. The end point was defined as a ≥ 20% decrease in estimated glomerular filtration from baseline.
RESULTS: We enrolled 75 children, including 36 children with IgAN and 39 with HSPN. The prevalence of C4d deposition was 36% (27/75). C4d deposition was more abundant in children with proteinuria ≥ 50 mg/kg/day (51.9% versus 20.8%, P = 0.006) or nephrotic syndrome (37.0% versus 10.4%, P = 0.006). Mesangial hypercellularity (hazard ratio [HR], 5.745, 95% confidence interval [CI], 1.670-19.761, P = 0.006) and IgM deposition (HR, 4.522, 95% CI, 1.321-15.478, P = 0.016) were associated with C4d deposition. After a median follow-up of 22 months, seven (19.4%) IgAN patients and one (2.6%) HSPN patient had decreased kidney function. In children with IgAN, positive C4d was associated with decreased kidney function (P = 0.047).
CONCLUSION: Glomerular C4d deposition was associated with mesangial hypercellularity and glomerular IgM deposition in IgAN and HSPN. Glomerular C4d deposition may be a risk factor for eGFR decline in children with IgAN. A higher resolution version of the Graphical abstract is available as Supplementary information.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  C4d staining; Children; Glomerulonephritis; Henoch-Schönlein purpura nephropathy; IgA nephropathy; IgA vasculitis with nephritis

Year:  2022        PMID: 35697863     DOI: 10.1007/s00467-022-05585-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

Review 1.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

2.  Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.

Authors:  Anja Roos; Maria Pia Rastaldi; Novella Calvaresi; Beatrijs D Oortwijn; Nicole Schlagwein; Danielle J van Gijlswijk-Janssen; Gregory L Stahl; Misao Matsushita; Teizo Fujita; Cees van Kooten; Mohamed R Daha
Journal:  J Am Soc Nephrol       Date:  2006-05-10       Impact factor: 10.121

Review 3.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

Authors:  J C Davin; I J Ten Berge; J J Weening
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

4.  Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.

Authors:  Rafaela Cabral Gonçalves Fabiano; Stanley de Almeida Araújo; Eduardo Alves Bambirra; Eduardo Araújo Oliveira; Ana Cristina Simões E Silva; Sérgio Veloso Brant Pinheiro
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

5.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

Review 6.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

7.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

8.  Predicting progression of IgA nephropathy: new clinical progression risk score.

Authors:  Jingyuan Xie; Krzysztof Kiryluk; Weiming Wang; Zhaohui Wang; Shanmai Guo; Pingyan Shen; Hong Ren; Xiaoxia Pan; Xiaonong Chen; Wen Zhang; Xiao Li; Hao Shi; Yifu Li; Ali G Gharavi; Nan Chen
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 9.  Role of complement in IgA nephropathy.

Authors:  Mohamed R Daha; Cees van Kooten
Journal:  J Nephrol       Date:  2015-11-13       Impact factor: 3.902

10.  Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.

Authors:  Nicholas R Medjeral-Thomas; Hannah J Lomax-Browne; Hannah Beckwith; Michelle Willicombe; Adam G McLean; Paul Brookes; Charles D Pusey; Mario Falchi; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2017-06-30       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.